¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ) : 2020-03-13

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ) : 2020-03-13
±³À°ÀÏÀÚ : 2020-03-13
±³À°Àå¼Ò : ±×·£µå ¿öÄ¿ÈúÈ£ÅÚ VISTA  
±³À°ÁÖÁ¦ : 2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ)
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷¾×ÇÐȸ
´ã´çÀÚ : ±èÇýÁø
¿¬¶ôó : 02-516-6581  
À̸ÞÀÏ : hematology@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Áø´Ü°Ë»çÀÇÇаú      
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í »çÀüµî·Ï 100,000¿ø ÇöÀåµî·Ï 200,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03-13 VISTA 1 09:00~09:20 The Evil Side of Gene Regulation in AML  Ruud delwel(Erasmus MC University 'The Netherlands) 
±³À°½Ã°£ 03-13 VISTA 1 09:20~09:40 Clonal Evolution under IDH Inhibitor Therapy in Acute Myeloid Leukaemia  Lynn Quek UK(University of Oxford UK) 
±³À°½Ã°£ 03-13 VISTA 1 09:40~10:00 TET Loss-of-Function in Malignant Hematopoiesis  Myunggon Ko(UNIST) 
±³À°½Ã°£ 03-13 VISTA 1 10:00~10:30 NRAS Mutant AML  Taebo Sim(KU-KIST) 
±³À°½Ã°£ 03-13 VISTA 1 10:45~11:15 Translational Cancer Research in B-Cell Malignancies  John Gribben(Barts Cancer Institute UK) 
±³À°½Ã°£ 03-13 VISTA 1 11:15~11:45 Myelodysplastic Syndrome and Predisposition to Myeloid Neoplasia in Children and Adolescents  Charlotte Niemeyer(University of Freiburg Germany) 
±³À°½Ã°£ 03-13 VISTA 1 11:45~12:05 Outcome of Autologous Transplant in T Cell Lymphoma: Experience of NIHBT in Vietnam  Nguyen Vu Bao Anh(Hanoi Medical University Vietnam) 
±³À°½Ã°£ 03-13 VISTA 1 12:05~12:25 Subcutaneous Panniculitis-like T-cell Lymphoma  Udomsak Bunworasate(King Chulalongkorn Memorial Hosptal Thailand) 
±³À°½Ã°£ 03-13 VISTA 1 12:25~12:45 Update of Extranodal NK/T-cell Lymphoma: Treatment and Biology  Seok Jin Kim(Sungkyunkwan University) 
±³À°½Ã°£ 03-13 VISTA 1 12:45~13:40 Optimizing Treatment of IMiDs in Newly Diagnosed Multiple Myeloma  Philippe Moreau(Nantes University Hospital France) 
±³À°½Ã°£ 03-13 VISTA 1 14:10~15:10 Heterogeneous outcome after allogeneic stem cell transplantation according to type of KIT mutation in Core binding factor acute myeloid leukemia (CBF-AML): D816V and/or D816Y mutation represents worst outcome  Silvia Park(Catholic University of Korea) 
±³À°½Ã°£ 03-13 VISTA 1 15:25~16:25 Clinical Significance Of Genetic And Epigenetic Expression of PTEN In Chronic Myeloidic Leukemia Patients  Asgar Ali(India Institute of Medical Sciences Patna India) 
±³À°½Ã°£ 03-13 VISTA 1 16:40~17:10 Challenges in the Diagnosis of Bone Marrow Failure Syndromes: The Role of Genetic Panels?  Ghulam J Mufti(King's College Hospital UK) 
±³À°½Ã°£ 03-13 VISTA 1 17:10~17:40 Clonal Hematopoesis in Bone Marrow Failure  Daria V. Babushok(University of Pennsylvania USA) 
±³À°½Ã°£ 03-13 VISTA 1 17:40~18:10 he Current Treatment Algorithm for Patients with Acquired Aplastic Anemia in Japan  Shinji Nakao(Kanazawa University Japan) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ-ICKSH 2020 (3¿ù 13ÀÏ) : 2020-03-13""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ 14th Asian-Australasian Federation of Intervention and Therapeutic Neuroradiology (AAFITN 2020) : 2020-03-13
´ÙÀ½±Û ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ 14th Asian-Australasian Federation of Intervention and Therapeutic Neuroradiology (AAFITN 2020) : 2020-03-12
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 58 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 39 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 40 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 51 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 42 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 37 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 14 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 14 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 34 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 17 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 15 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 37 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 27 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 31 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 24 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷